Asia & Pacific

Magazine articles on conducting business in Asia and Pacific countries.

Old Articles: <Older 3931-3940 Newer>

The Motley Fool October 25, 2011 Dan Radovsky	Juniper Looks to Increase Asian Presence A poor earnings showing isn't stopping Juniper Networks from shopping around.
The Motley Fool October 25, 2011 Dan Caplinger	Has Melco Crown Become the Perfect Stock? Melco continues to enjoy strong growth. With a high valuation, no dividend, and still-mediocre net margins and returns on equity, though, Melco has a long way to go to reach perfection.
The Motley Fool October 24, 2011 Rick Aristotle Munarriz	Don't Fall Into This Blank Trap Rediff.com isn't the story stock you think it is. Rediff.com was "the Google of India" when it was trading in the double digits for the first time in more than three years back in April.
The Motley Fool October 24, 2011 Eric Bleeker	Disney: Looking at the International Opportunity While theme parks are only just about 28% of Disney's total revenues, the opening of Hong Kong Disney in 2005 and the planned Shanghai resort both illustrate the company's commitment to expanding its brand within China.
The Motley Fool October 21, 2011 John Rosevear	GM's China Success Continues The General's having another record year in China -- but challenges remain.
The Motley Fool October 21, 2011 Dan Radovsky	China Questions Big Four Auditors The Chinese government wants the big auditing firms to double-check their work.
The Motley Fool October 20, 2011 John Rosevear	Why China's Slowdown Shouldn't Hurt Ford The world's biggest auto market is slowing, just as Ford is finally ramping up. Here's why it might not matter.
Pharmaceutical Executive October 1, 2011 William Looney	The East is Up Candan Karabagli is CEO of Turkey's largest pharmaceutical company, Abdi Ibrahim, where she is responsible for consolidating the company's lead position in Turkey through more in-house R&D and licensing deals with innovative companies while building a stronger regional footprint.
Pharmaceutical Executive October 1, 2011 William Looney	Productivity, Reputation are Keys to Global Leadership As CEO of Japan's largest pharmaceutical company and chair of Keizai Doyukai representing Japan's corporate business community, Yasuchika Hasegawa has the platform to pursue a two-pronged agenda that artfully fuses global and domestic priorities.
Pharmaceutical Executive October 1, 2011 Amrita Ghaswalla	Changing the Dialogue No industry leader is more closely associated with the goal of seeding the globe with low-cost generics than Mumbai-based Cipla Chairman Y.K. Hamied.
<Older 3931-3940 Newer> Return to current articles.